Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Andrzej Jakubowiak
Selinexor‐based Regimens for the Treatment of Myeloma Refractory to Chimeric Antigen Receptor T Cell Therapy
British Journal of Haematology
Hematology
Split First Dose Administration of Intravenous Daratumumab for the Treatment of Multiple Myeloma (MM): Clinical and Population Pharmacokinetic Analyses
Advances in Therapy
Medicine
Pharmacology
Related publications
Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma
International Journal of Hematology
Hematology
Chimeric Antigen Receptor T Cell Therapies for Multiple Myeloma
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors
Molecular Therapy - Oncolytics
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Prospects to Improve Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors
Immunotherapy
Oncology
Allergy
Immunology
Chimeric Antigen Receptor T Cell Targeting B Cell Maturation Antigen Immunotherapy Is Promising for Multiple Myeloma
Annals of Hematology
Medicine
Hematology
Clinical Chimeric Antigen Receptor‐T Cell Therapy: A New and Promising Treatment Modality for Glioblastoma
Clinical and Translational Immunology
Allergy
Immunology
Nursing
Advancing Chimeric Antigen Receptor T Cell Therapy With CRISPR/Cas9
Protein & Cell
Biochemistry
Biotechnology
Drug Discovery
Cell Biology
Medicine
Cytokine Release Syndrome With Chimeric Antigen Receptor T Cell Therapy
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Chimeric Antigen Receptor T-Cell Therapy for Acute Myeloid Leukaemia : How Close to Reality?
Haematologica
Hematology
